跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 35,794 条关于
“pulmonary arterial hypertension (PAH)”
全部
35,794
临床试验
32,131
药物
759
机构
94
资讯
2,810
2年前
Liquidia's Yutrepia Receives Tentative FDA Approval for Pulmonary Hypertension
去年
Inhibikase Therapeutics Secures $275M Financing, Advances IkT-001Pro for Pulmonary Arterial Hypertension
去年
Cereno Scientific Secures Funding to Advance Pulmonary Hypertension and Fibrosis Programs
去年
Merck's Winrevair Shows Significant Morbidity and Mortality Reduction in PAH Patients
去年
Liquidia Secures $100M Financing to Advance Yutrepia for Pulmonary Hypertension Treatment
去年
XOMA Royalty Acquires Pulmokine for $20 Million, Expanding PAH Portfolio with Seralutinib
去年
Merck Halts Phase 3 HYPERION Trial of Winrevair Early After Positive ZENITH Results
8个月前
Liquidia Reports Strong YUTREPIA Launch with $148.3M in Full-Year 2025 Sales, Expands Clinical Pipeline
去年
Merck's Winrevair Shows Overwhelming Efficacy in Phase 3 ZENITH Trial for Advanced PAH
去年
United Therapeutics to Present Tyvaso DPI Data at CHEST 2024
第 1 页，共 281 页
上一页
下一页
